Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. DLA Piper's Kirsten Axelsen and Sarah Schick are joined by Shazia Ahmad, Senior Director and Head of Patient and Physician Services at UBC, to discuss the importance of regulatory incentives to drive racial and ethnic diversity in clinical trials.

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
29:37

Life sciences companies and the risks posed by the mifepristone litigation
33:17

Trade secrets protection in the life sciences sector
21:22